Additionally, TRPV1 was found to be aberrantly expressed by various factors in tumors, such as inflammation, tissue damage, and hypoxic conditions33, suggesting that TRPV1 expression in tumor cells could be mediated by various tumor microenvironmental factors as well as several different stemness factors besides NANOG. The gene discussed is NANOG; the disease is neoplasm.